Symbiotec Pharmalab Limited
Mainboard IPO
Risk analysis not yet reviewed. ClearIPO publishes risk factors only after a manual review of the offer document.
Last updated 26 Aug 2026
Key details
- Price band
- ₹938 to ₹988
- Face value
- Rs 10
- Lot size
- 15 shares
- Minimum investment
- Rs 14,820
- Issue size
- Rs 1,757 Cr
- Fresh issue
- Rs 1,757 Cr
- Retail quota
- 35%
- Exchanges
- BSE, NSE
- Opening date
- 24 Aug 2026
- Closing date
- 27 Aug 2026
- Allotment date
- 28 Aug 2026
- Listing date
- 31 Aug 2026
3 further details have not been reported for this issue yet, so they are left out rather than estimated.
Explain this IPO simply
The same information as the prospectus, written the way you would explain it to a friend.
What the company does
Symbiotec Pharmalab is a pharmaceutical company engaged in developing and manufacturing active pharmaceutical ingredients, contract development and manufacturing solutions, and complex injectables. The company operates an integrated business model supported by research and development, fermentation, and organic chemistry capabilities. Its active pharmaceutical ingredient portfolio primarily focuses on steroidal products, while its contract development and manufacturing business offers development and manufacturing services for pharmaceutical, nutraceutical, and other life science companies. The company also develops complex injectable products, including double-chamber formats, and leverages its in-house active pharmaceutical ingredient capabilities to support these offerings. Revenue is generated through the sale of active pharmaceutical ingredients, contract development and manufacturing services, and complex injectable products. Its business is supported by backward integration in key raw material processing, large-scale fermentation capacity, and multiple manufacturing facilities, enabling it to serve customers across regulated and global markets.
No hand-checked analysis for this issue yet
Subscription status
Not reported
Final subscription figures were not reported by the source.
Important documents
IPO timeline
IPO opens
24 Aug 2026
First day you can apply.
IPO closes
27 Aug 2026
Last day to apply, usually by evening.
Allotment
28 Aug 2026
Who gets shares is decided.
Refund / unblock
29 Aug 2026
Blocked money is released if you did not get shares.
Shares in demat
29 Aug 2026
Allotted shares reach your demat account.
Listing day
31 Aug 2026
Shares start trading on the exchange.
Frequently asked questions
Where this information comes from
- Last updated
- 2026-08-26T03:45:08.260Z
- Last verified
- 2026-08-26T03:45:08.260Z
- Primary source
- bse
- Secondary source
- Exchange filings
